Jefferies Financial Group Inc. Purchases Shares of 126,303 Aspen Aerogels, Inc. $ASPN

Jefferies Financial Group Inc. acquired a new stake in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 126,303 shares of the construction company’s stock, valued at approximately $801,000.

Other hedge funds have also recently made changes to their positions in the company. Raymond James Financial Inc. grew its position in shares of Aspen Aerogels by 6.8% during the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after purchasing an additional 1,687 shares in the last quarter. Legal & General Group Plc lifted its holdings in Aspen Aerogels by 3.6% in the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after purchasing an additional 2,324 shares in the last quarter. Osaic Holdings Inc. boosted its stake in Aspen Aerogels by 29.1% in the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after purchasing an additional 2,390 shares during the period. The Manufacturers Life Insurance Company boosted its stake in Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock worth $146,000 after purchasing an additional 2,656 shares during the period. Finally, Deutsche Bank AG grew its holdings in Aspen Aerogels by 1.3% during the 4th quarter. Deutsche Bank AG now owns 223,093 shares of the construction company’s stock valued at $631,000 after buying an additional 2,880 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Wall Street Zen downgraded shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. B. Riley Financial reiterated a “buy” rating on shares of Aspen Aerogels in a report on Friday, August 7th. Barclays boosted their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 11th. Finally, Roth Capital reissued a “buy” rating and set a $7.75 price objective on shares of Aspen Aerogels in a report on Friday, August 7th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $5.94.

Check Out Our Latest Stock Report on Aspen Aerogels

Aspen Aerogels Stock Performance

NYSE ASPN opened at $4.93 on Monday. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. Aspen Aerogels, Inc. has a 1-year low of $2.30 and a 1-year high of $9.35. The business has a 50 day simple moving average of $5.40 and a two-hundred day simple moving average of $4.65. The stock has a market capitalization of $409.14 million, a PE ratio of -3.22 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The business had revenue of $49.85 million for the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. On average, research analysts predict that Aspen Aerogels, Inc. will post -0.69 EPS for the current fiscal year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Further Reading

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.